The Office of HIV/AIDS Network Coordination (HANC) works with the HIV/AIDS Clinical Trials Networks of the U.S. National Institutes of Health (NIH) with the intent of creating a more integrated, collaborative and flexible research structure. The networks are an affiliated group of national and international medical research institutions and investigators that conduct clinical HIV/AIDS research to develop safe and effective drugs, prevention strategies, and vaccines.
The Guill-Lebovic Center for Community Health in the Caribbean and Latin America at the George Washingotn University-Milken Institute School of Public Health is looking for:
These positions are based in Washington, DC, an epicenter for public health, global affairs, and international collaborations. For questions contact Carlos Rodriguez-Diaz at firstname.lastname@example.org.
We are pleased to announce the promotion of Russell Campbell to the Office of HIV/AIDS Network Coordination (HANC) Director position, effective October 10, 2022.
Russell joined HANC (located at Fred Hutchinson Cancer Center) in 2008. For the past seven years, Russell has served in a leadership role as HANC Deputy Director providing oversight and strategic direction for all cross-network coordination activities. Most recently, Russell stepped in as HANC Acting Director while we conducted our search to fill this role. Russell’s demonstrated ability for program management, commitment to building collaborative relationships, and longevity within HANC are all attributes that make Russell uniquely qualified. Please join us in congratulating Russell in his new role as HANC Director.
The Office of HIV/AIDS Network Coordination (HANC) programs are referred to as areas of coordination. Within each area of coordination are numerous work groups that are integral to advancing the research goals and objectives defined by the HIV/AIDS Clinical Trials Networks and the Division of AIDS.
HANC supports a number of trans-institute behavioral science groups composed of experts that are working to advance research and clinical trials through cross-network collaboration.
HANC supports Community Partners, The Legacy Project, and the COVID-19 CAB coalition to achieve representation and build relationships with historically underrepresented communities in clinical research.
HANC supports cross-network working groups for network leadership, communications, data management centers, performance evaluation, and site coordinators to promote greater information sharing, collaboration, and process standardization.
HANC supports several cross-network laboratory working groups and committees with the aim of harmonizing processes and procedures, ensuring standard quality assurance for protocol-specified assays and laboratory preparedness for network clinical trials.
Working together, we can be the generation to end the HIV/AIDS epidemic. Know the facts, spread the word, volunteer for a study, or join a community advisory board.